Adult Immunization Allergy & Immunology Cardiology Dermatology Endocrinology Gastroenterology Infectious Disease Men’s Health Nephrology Neurology Pain Management Pediatric Immunization Pediatrics Psychiatry Pulmonology Rheumatology Women’s Health

Billing and Collections Career Planning Coding and Documentation Concierge Medicine Cybersecurity EHRs Investing Patient Relations Personal Finance Practice Management Remote Patient Monitoring Staffing Technology Telehealth Value-based Care

Unmet Needs in Managing MDD Interpreting Thyroid Function Tests Using Thyroid Lab Tests Testing & Screening to Optimize Men's Health

Pulmonology

Latest News

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope ©New Africa/AdobeStock

Daily Dose: Long-COVID Rehabilitation Interventions

By Sydney Jennings

September 28th 2023

Your daily dose of the clinical news you may have missed.

Daily Dose: Dupilumab Potent Against Uncontrolled COPD with Type 2 Inflammation

By Sydney Jennings

September 26th 2023

Long COVID Rehab Interventions Improve but Safety Research still needed image credit ©Nejron Photo/stock.adobe.com

Long-COVID Rehabilitation Interventions Improve Symptoms but Research on Safety Still Needed

By Grace Halsey

September 21st 2023

Dupilumab Potent Against Uncontrolled COPD with T2 Inflammation: BOREAS Trial Update

By Grace Halsey

September 15th 2023

Remdesivir Gets FDA “OK” for COVID-19 Treatment in Hepatic Disease Across Stages

By Grace Halsey

August 25th 2023

Latest CME Events & Activities

Community Practice Connections™: Chronic Fibrosing ILDs With Progressive Phenotype–Are You Aware of the Latest Data on Diagnosis and Emerging Treatments?

Catching Them Early: A Real-World Case Discussion on the Application of Testing Methodologies to Identify Key Markers Across NSCLC

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®

18th Annual New York Lung Cancers Symposium®

Medical Crossfire: How Should We Leverage Multidisciplinary Lung Cancer Care Teams in Managing Earlier Forms of NSCLC... When the Goal Is Cure?

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

2023 Respiratory Summit

Advancing Precision Care Through Biomarker-Driven Therapy: CEACAM5 as a Therapeutic Target in NSCLC

Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

Addressing Healthcare Inequities: Overcoming Challenges in the Equitable Management of Idiopathic Pulmonary Fibrosis

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

Addressing Healthcare Inequities: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

Show Me Your Care Plan™: Monitoring and Managing Patients With EGFR Exon20 Insertion+ NSCLC

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

2nd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™

Community Practice Connections™: 17th Annual New York Lung Cancers Symposium

Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

Navigating the Latest Data on NTRK-Targeted Therapies

Trekking Through the Latest Updates for ROS1-Targeted Therapies

Mapping Out the Role of Emerging Biomarkers and Testing in NSCLC

Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

21st Annual Winter Lung Cancer Conference®

Community Practice Connections™: Guidebook for Community Oncology NSCLC Treating Teams to Administer EGFR Exon 20-Targeted Regimens

Community Practice Connections™: 1st Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™

More News

Exacerbations in asthma and COPD - guidelines quiz

Exacerbations in Asthma and COPD: A GINA & GOLD Guideline Quiz

Veronica Hackethal, MD

November 30th 2020

Exacerbations of asthma and COPD have a negative impact on disease process in both conditions. Find out what you know about guideline-recommended mitigation.

Baseline FeNo level predicts response to dupilumab in severe asthma

Response to Dupilumab in Severe Asthma Predicted by Baseline FeNo

Grace Halsey

November 17th 2020

Increasing baseline FeNo levels were associated with reduced exacerbation and greater lung function improvement in dupilumab-vs-placebo-treated patients.

Increased Blood Eosinophil Counts, IgE Levels Linked to Higher Exacerbation Rates in Severe Asthma

Sydney Jennings

November 17th 2020

Increased blood eosinophil counts and IgE levels are associated with higher exacerbation rates in patients with severe asthma, according to new research presented at ACAAI 2020.

Asthma, COPD, & Asthma-COPD Overlap: A Quiz in Differential Diagnostics

Veronica Hackethal, MD

November 16th 2020

Distinguishing asthma and COPD can at times be problematic and the asthma-COPD overlap picture is even less clear. Check your recall of GINA/GOLD guidelines on all 3.

Severe Asthma: A 5-question POP Quiz

C. Andrew Schroeder, MD

November 13th 2020

Severe asthma affects 5% to 10% of adults with asthma. Find out what you know about diagnosis and treatment options for these patients with 5 no-nonsense questions.

Tezepelumab for severe uncontrolled asthma

Tezepelumab for Severe Asthma Meets Phase 3 Primary Endpoint

Grace Halsey

November 10th 2020

The novel monoclonal antibody could bring relief to millions of persons with severe, uncontrolled asthma, including those with a low eosinophil phenotype.

COPD Self-management App Reduces Exacerbations, Readmissions vs Usual Care

Grace Halsey

November 6th 2020

Use of the myCOPD app after hospitalization for acute COPD exacerbation reduced subsequent exacerbations by nearly 50%, according to study authors.

ATS 2020: Masitinib Significantly Reduces Severe Asthma Exacerbations

Sydney Jennings

October 19th 2020

New research presented at the American Thoracic Society virtual symposium showed the first-in-class drug reduced severe asthma exacerbation rate by 35% vs placebo.

COPD, lung function decline, cardiovascular disease and COPD

CVD Mortality in COPD Related to Factors Other than Lung Function Decline

Grace Halsey

October 5th 2020

In COPD patients, a new study found no association between lung function decline and individual CVD outcomes, but disease exacerbations and dyspnea were implicated.

FDA Approves First Drug to Treat Group of Rare Blood Disorders in Over 10 Years

Sydney Jennings

September 30th 2020

Mepolizumab (Nucala) received a new indication for the treatment of hypereosinophilic syndrome in patients aged ≥12 years.

FDA Approves First Once-daily Single Inhaler Triple Therapy for Both Asthma, COPD Treatment

Sydney Jennings

September 16th 2020

Along with COPD, fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) is now approved for the treatment of asthma in patients aged ≥18 years.

US Adolescent E-cigarette Users at Increased Risk for COVID-19

Sydney Jennings

August 17th 2020

A new survey found adolescents who have ever used e-cigarettes are 5-times more likely to receive a COVID-19 diagnosis. More results at-a-glance in our new slideshow.

Survey: Youth Vapers are Five Times More Likely to Contract COVID-19

Sydney Jennings

August 12th 2020

A new survey suggests use of e-cigarettes and dual use of e-cigarettes and traditional cigarettes are significant underlying risk factors for COVID-19 among US adolescents.

ATS 2020: Novel At-home Rapid Influenza Diagnostic Test Demonstrates Good Sensitivity, Specificity

Sydney Jennings

August 11th 2020

New research presented at the American Thoracic Society 2020 Virtual meeting showed the novel Theraflu Home FluTest demonstrated good sensitivity and specificity for influenza A and B viruses.

Adolescents Who Use E-cigarettes, Marijuana Have Higher Odds of Lifetime Asthma

Sydney Jennings

August 10th 2020

New research presented at the ATS 2020 Virtual meeting shows adolescents who use e-cigarettes along with marijuana and/or cigarette smoking have significantly higher odds of lifetime asthma.

USPSTF: New Lung Cancer Screening Recommendations Will Double Number of Eligible Patients

Sydney Jennings

July 14th 2020

The proposed recommendations will allow more women and black patients to be eligible for lung cancer screening.

Lung Disease and E-Cigarette Use: 9 Recommendations for Clinicians

Sydney Jennings

September 17th 2019

There have been 7 e-cigarette-linked deaths in the US. A new CDC Health Advisory offers 9 recommendations for clinicians who suspect a vaping-related lung illness.

<1 2 3 4 5 6

Advertise

Terms and Conditions

Privacy

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777